Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis

Pirfenidone and nintedanib are oral antifibrotic agents approved for the treatment of idiopathic pulmonary fibrosis (IPF). Real-world data on factors that influence IPF treatment decisions are limited. Physician characteristics associated with antifibrotic therapy initiation following an IPF diagnos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Chron Respir Dis
Autores principales: LaCamera, Peter P, Limb, Susan L, Haselkorn, Tmirah, Morgenthien, Elizabeth A, Stauffer, John L, Wencel, Mark L
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2019
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6764076/
https://ncbi.nlm.nih.gov/pubmed/31558049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479973119879678
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares